ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.
Choksi Laboratories board approved a preferential issue of 3.5 lakh warrants to promoters at Rs 177 per warrant, totaling Rs 6.195 Crore.
Choksi Laboratories filed proceedings of its 33rd AGM held on 18 September 2026. Directors Sunil Choksi and Himika Choksi were re-appointed as Whole-Time Directors.
Choksi Laboratories announced a Board meeting on September 19, 2026, to discuss a proposal for raising funds through equity or convertible securities.
Choksi Laboratories Limited has dispatched letters to shareholders with unregistered email addresses. The communication provides access details for the FY 2025-26 Annual Report and AGM notice.
Choksi Laboratories has submitted its 33rd Annual Report for the financial year 2025-26. The report and the notice of the upcoming AGM are now available.
Choksi Laboratories Limited has issued the notice for its 33rd Annual General Meeting, scheduled to be held on September 18, 2026, through video conferencing.
Choksi Laboratories reported that the USFDA inspected its central laboratory in Indore. The inspection concluded with four observations, which the company is currently addressing.
Choksi Laboratories has reappointed M/s Tanmay V. Rajurkar & Co. as the company's internal auditor for the financial year 2026-27.
Choksi Laboratories Ltd has re-appointed Ms. Himika Choksi as Whole Time Director for a five-year term effective from April 1, 2027, subject to shareholder approval.
Choksi Laboratories Ltd reported revenue from operations of ₹12.1 Cr (+8.0% YoY) and net profit of ₹0.6 Cr (+50.0% YoY) for Q1 FY27.